These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6323515)

  • 41. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
    Alberts AW; Chen J; Kuron G; Hunt V; Huff J; Hoffman C; Rothrock J; Lopez M; Joshua H; Harris E; Patchett A; Monaghan R; Currie S; Stapley E; Albers-Schonberg G; Hensens O; Hirshfield J; Hoogsteen K; Liesch J; Springer J
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):3957-61. PubMed ID: 6933445
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Steroidogenesis in the human fetal adrenal: a role for cholesterol synthesized de novo.
    Mason JI; Rainey WE
    J Clin Endocrinol Metab; 1987 Jan; 64(1):140-7. PubMed ID: 3023427
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exogenous CoQ10 preserves plasma ubiquinone levels in patients treated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Bargossi AM; Battino M; Gaddi A; Fiorella PL; Grossi G; Barozzi G; Di Giulio R; Descovich G; Sassi S; Genova ML
    Int J Clin Lab Res; 1994; 24(3):171-6. PubMed ID: 7819598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition on human gut mucosa.
    Gebhard RL; Ewing SL; Schlasner LA; Hunninghake DB; Prigge WF
    Lipids; 1991 Jul; 26(7):492-4. PubMed ID: 1943491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.
    Tobert JA; Bell GD; Birtwell J; James I; Kukovetz WR; Pryor JS; Buntinx A; Holmes IB; Chao YS; Bolognese JA
    J Clin Invest; 1982 Apr; 69(4):913-9. PubMed ID: 6918402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A possible translational control of 3-hydroxy-3-methylglutaryl coenzyme A reductase induction by ML-236b(compactin) in isolated rat hepatocytes.
    Koizumi J; Mabuchi H; Takeda R; Okamoto H
    Biochem Biophys Res Commun; 1982 Sep; 108(1):240-6. PubMed ID: 7150285
    [No Abstract]   [Full Text] [Related]  

  • 47. Sources of extramitochondrial corticoidogenic cholesterol in the adrenal cortex.
    Iwaki T; Noguchi A; Sekimoto T
    Jpn J Pharmacol; 1985 Jun; 38(2):207-14. PubMed ID: 2993719
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypolipidemic effects in dogs of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Tsujita Y; Kuroda M; Tanzawa K; Kitano N; Endo A
    Atherosclerosis; 1979 Mar; 32(3):307-13. PubMed ID: 223590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Testicular function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin) or neomycin.
    Farnsworth WH; Hoeg JM; Maher M; Brittain EH; Sherins RJ; Brewer HB
    J Clin Endocrinol Metab; 1987 Sep; 65(3):546-50. PubMed ID: 3114306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypolipidemic effects of CS-500 (ML-236B) in WHHL-rabbit, a heritable animal model for hyperlipidemia.
    Watanabe Y; Ito T; Saeki M; Kuroda M; Tanzawa K; Mochizuki M; Tsujita Y; Arai M
    Atherosclerosis; 1981; 38(1-2):27-31. PubMed ID: 7470202
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Compactin (ML-236B) reduces the content of filipin-cholesterol complexes in the plasma membrane of chronic lymphocytic leukemia cells.
    Madden EA; Melnykovych G; Fiskin AM
    Exp Cell Res; 1984 Jul; 153(1):91-8. PubMed ID: 6610562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase.
    Brown MS; Faust JR; Goldstein JL; Kaneko I; Endo A
    J Biol Chem; 1978 Feb; 253(4):1121-8. PubMed ID: 624722
    [No Abstract]   [Full Text] [Related]  

  • 53. Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity.
    Endo A; Kuroda M; Tanzawa K
    FEBS Lett; 1976 Dec; 72(2):323-6. PubMed ID: 16386050
    [No Abstract]   [Full Text] [Related]  

  • 54. A two component-type cytochrome P-450 monooxygenase system in a prokaryote that catalyzes hydroxylation of ML-236B to pravastatin, a tissue-selective inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Serizawa N; Matsuoka T
    Biochim Biophys Acta; 1991 Jun; 1084(1):35-40. PubMed ID: 1905157
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amelioration of proteinuria with pravastatin in hypercholesterolemic patients with diabetes mellitus.
    Sasaki T; Kurata H; Nomura K; Utsunomiya K; Ikeda Y
    Jpn J Med; 1990; 29(2):156-63. PubMed ID: 2122049
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Crilvastatin, a new 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, inhibits cholesterol absorption in genetically hypercholesterolemic rats.
    Hajri T; Férézou J; Laruelle C; Lutton C
    Eur J Pharmacol; 1995 Nov; 286(2):131-6. PubMed ID: 8605949
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A mechanism for the in vitro stimulation of adrenal cortisol biosynthesis by epidermal growth factor.
    Singh-asa P; Waters MJ; Wilce PA
    Int J Biochem; 1985; 17(8):857-62. PubMed ID: 2995161
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic effects of ml-236B in primary hypercholesterolemia. 1980.
    Yammoto A; Sudo H; Endo A
    Atheroscler Suppl; 2004 Oct; 5(3):43-50. PubMed ID: 15531274
    [No Abstract]   [Full Text] [Related]  

  • 59. Monacolin K, a new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Endo A
    J Antibiot (Tokyo); 1980 Mar; 33(3):334-6. PubMed ID: 7380744
    [No Abstract]   [Full Text] [Related]  

  • 60. The effects of mevinolin on serum cholesterol levels of rabbits with endogenous hypercholesterolemia.
    Kroon PA; Hand KM; Huff JW; Alberts AW
    Atherosclerosis; 1982 Jul; 44(1):41-8. PubMed ID: 6921995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.